Dietary Peanuts and Nutrition-Related Outcomes
Ian J. Neeland, MD · NCT07244458
Opens the official ClinicalTrials.gov record, with the study team’s contacts. Bored Studies doesn’t enroll anyone.
Key facts
- Compensation
- Not posted. Ask the study team before screening.
- Who can join
- Ages 18–80 · All sexes
- Healthy volunteers
- Accepted
- Study type
- Interventional · Not applicable
- Target enrollment
- 64
- US sites recruiting
- 1
- Study start
- April 20, 2026
- Record last updated
- April 23, 2026
Status re-checked against ClinicalTrials.gov within the last 12 hours.
What the study is about
This study will look at how eating peanuts every day might affect participants weight, how healthy their diet is, and how they feel when eating. Investigators want to see if adding peanuts to meals for 12 weeks helps participants feel fuller, have more energy, and improve body composition. The study will include adults who have been taking GLP-1 medicines like semaglutide or tirzepatide for at least three months. Investigators also want to see if eating peanuts improves overall diet quality and health markers like tiredness and certain levels in blood.
Being studied: Peanuts; Dual-energy X-ray absorptiometry (DEXA) scans
Conditions: Dietary Change; Obesity & Overweight; Food Acceptance
Eligibility criteria
Copied from the official record. The study team makes the final decision at screening.
Show full criteria
Inclusion Criteria
- Individuals with a BMI ≥30 kg/m2 or with a BMI ≥27 kg/m2 with at least one weight-related comorbidity who have been using semaglutide or tirzepatide for a clinical indication or at least 6 months
Exclusion Criteria
- No use or contraindication to use of a GLP-1 RA
- Known allergy to nuts
- Pregnant or breastfeeding
- Incarcerated
Recruiting US locations
University Hospitals Cleveland Medical Center
Clevland, OH 44106
Site contact: Ian Neeland, MD · 216-844-5965 · Ian.Neeland@UHhospitals.org
Study contacts (from the official record)
- Ian Neeland, MD · 216-844-5965 · Ian.Neeland@UHhospitals.org
- Abigail Raffner, PhD, RD, LD · 216-368-0756 · Abigail.Raffner@UHhospitals.org
Similar studies in Ohio
All weight loss studies in Ohio →- RecruitingHealthy volunteersPhase 1Overnight stay mentioned
A Single and Multiple Ascending Dose Study of HM17321 in Healthy and Obese Participants
Hanmi Pharmaceutical Company Limited
- Location
- Cincinnati, OH
- Eligibility basics
- Ages 18–65
- RecruitingHealthy volunteersPhase 3
A Study of Aleniglipron in Adults With Obesity or Overweight and Type 2 Diabetes Mellitus (ACCOMPLISH-2)
Gasherbrum Bio, Inc., a wholly owned subsidiary of Structure Therapeutics
- Location
- Columbus, OH + 55 other US sites
- Eligibility basics
- Ages 18–79
- RecruitingPhase 2
Safety and Efficacy of ABBV-295 in Adults With Obesity or Overweight With Weight-Related Comorbidities
AbbVie
- Location
- Cincinnati, OH + 58 other US sites
- Eligibility basics
- Ages 18–75
- RecruitingPhase 3
A Study to Learn About Switching to a Monthly Study Medicine Called Berobenatide (PF-08653944) to Help Keep Weight Off in People With Overweight or Obesity
Pfizer
- Location
- Cincinnati, OH + 4 other US sites
- Eligibility basics
- Ages 18+